Cargando…
Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country
Background: The majority of clinical practice guidelines do not recommend the use of SYSADOA (Symptomatic Slow Action Drugs for Osteoarthritis) for the treatment of osteoarthritis because of the lack of evidence or uncertainty around their efficacy. Nevertheless, the Spanish Public Health Service co...
Autores principales: | Ibargoyen-Roteta, Nora, Mateos del Pino, Maider, Gutiérrez-Ibarluzea, Iñaki, Benguria-Arrate, Gaizka, Rada-Fernández de Jauregui, Diego, Domingo-Rico, Cristina, Regidor Fuentes, Iratxe, González Santisteban, Roberto, Armendáriz Cuñado, María, Jaio Atela, Nekane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460939/ https://www.ncbi.nlm.nih.gov/pubmed/31015866 http://dx.doi.org/10.3205/hta000130 |
Ejemplares similares
-
Why and how can HTA support evidence-informed health policymaking?
por: Gutiérrez-Ibarluzea, I, et al.
Publicado: (2022) -
A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agencies
por: Ibargoyen-Roteta, Nora, et al.
Publicado: (2022) -
Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits
por: Permuy, María, et al.
Publicado: (2015) -
The GRADE approach for assessing new technologies as applied to apheresis devices in ulcerative colitis
por: Ibargoyen-Roteta, Nora, et al.
Publicado: (2010) -
Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain)
por: Portillo, Isabel, et al.
Publicado: (2017)